Table 4.
Forward multivariate logistic regression analysis to identify the risk factors for lipodystrophy
| Covariate | Odds ratio | 95% CI | p-value |
|---|---|---|---|
| Experience on stavudine | |||
| Never received* | 1.00 | - | - |
| ≤2.0 years | 25.46 | 9.01–71.97 | <0.001 |
| > 2.0 years | 14.92 | 5.29–42.06 | <0.001 |
| Experience on PI | |||
| Never received* | 1.00 | - | - |
| ≤2.6 years | 1.42 | 0.86–2.34 | 0.165 |
| > 2.6 years | 0.26 | 0.12–0.56 | <0.001 |
| Total duration on cART | |||
| ≤3.8 years* | 1.00 | - | - |
| > 3.8 years | 4.84 | 3.11–7.55 | <0.001 |
*
Reference category.
Abbreviations used: CI, confidential interval; PI, protease inhibitor; cART, combined antiretroviral treatment.